Genetic polymorphisms of IL17A and pri-microRNA-938, targeting IL17A 3'-UTR, influence susceptibility to gastric cancer

Human Immunology

Volumn 73, Issue 7, 2012, Pages 747-752

  Arisawa, Tomiyasu ^a   Tahara, Tomomitsu ^b   Shiroeda, Hisakazu ^a   Matsue, Yasuhito ^a   Minato, Takahiro ^a   Nomura, Tomoe ^a   Yamada, Hideto ^a   Hayashi, Ranji ^a   Saito, Takashi ^a   Matsunaga, Kazuhiro ^a   Fukuyama, Tomoki ^a   Hayashi, Nobuhiko ^a   Otsuka, Toshimi ^a   Fukumura, Atsushi ^a   Nakamura, Masakatsu ^a   Shibata, Tomoyuki ^b  

^a KANAZAWA MEDICAL UNIVERSITY   (Japan)

^b FUJITA HEALTH UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 17; MICRORNA; MICRORNA 938; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER RISK; CANCER SUSCEPTIBILITY; CARCINOGENESIS; CONTROLLED STUDY; DNA POLYMORPHISM; EARLY CANCER; FEMALE; GENE FREQUENCY; GENE LOCUS; GENETIC ASSOCIATION; GENOTYPE; HETEROZYGOTE; HOMOZYGOTE; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MULTIPLEX POLYMERASE CHAIN REACTION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; STOMACH CANCER;

3' UNTRANSLATED REGIONS; AGED; DNA MUTATIONAL ANALYSIS; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INTERLEUKIN-17; MALE; MICRORNAS; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK; STOMACH NEOPLASMS;

EID: 84862331970     PISSN: 01988859     EISSN: 18791166     Source Type: Journal    
DOI: 10.1016/j.humimm.2012.04.011     Document Type: Article

References (29)

1. NIH Consensus Conference Helicobacter pylori in peptic ulcer disease. NIH Consensus Development Panel on Helicobacter pylori in peptic ulcer disease. JAMA 1994, 272:65-69.
2. Uemura N., Okamoto S., Yamamoto S., Matsumura N., Yamaguchi S., Yamakido M., et al. Helicobacter pylori infection and the development of gastric cancer. N Engl J Med 2001, 345:784-789.
3. Parsonnet J., Friedman G.D., Vandersteen D.P., Chang Y., Vogelman J.H., Orentreich N., et al. Helicobacter pylori infection and the risk of gastric carcinoma. N Engl J Med 1991, 325:1127-1131.
4. Huang J.Q., Sridhar S., Chen Y., Hunt R.H. Meta-analysis of the relationship between Helicobacter pylori seropositivity and gastric cancer. Gastroenterology 1998, 114:1169-1179.
5. Blaser M.J., Parsonnet J. Parasitism by the 'slow' bacterium Helicobacter pylori leads to altered gastric homeostasis and neoplasia. J Clin Invest 1994, 94:4-8.
6. Blaser M.J., Berg D.E. Helicobacter pylori genetic diversity and risk of human disease. J Clin Invest 2001, 107:767-773.
7. Prinz C., Schoniger M., Rad R., Becker I., Keiditsch E., Wagenpfeil S., et al. Key importance of the Helicobacter pylori adherence factor blood group antigen binding adhesin during chronic gastric inflammation. Cancer Res 2001, 61:1903-1909.
8. El-Omar E.M., Carrington M., Chow W.H., McColl K.E., Bream J.H., Young H.A., et al. Interleukin-1 polymorphisms associated with increased risk of gastric cancer. Nature 2000, 404:398-402.
9. Furuta T., El-Omar E.M., Xiao F., Shirai N., Takashima M., Sugimura H. Interleukin 1β polymorphisms increase risk of hypochlorhydria and atrophic gastritis and reduce risk of duodenal ulcer recurrence in Japan. Gastroenterology 2002, 123:92-105.
10. Machado J.C., Figueiredo C., Canedo P., Pharoah P., Carvalho R., Nabais S., et al. A proinflammatory genetic profile increases the risk for chronic atrophic gastritis and gastric carcinoma. Gastroenterology 2003, 125:364-371.
11. Wu M.S., Wu C.Y., Chen C.J., Lin M.T., Shun C.T., Lin J.T. Interleukin-10 genotypes associate with the risk of gastric carcinoma in Taiwanese Chinese. Int J Cancer 2003, 104:617-623.
12. Ohyauchi M., Imatani A., Yonechi M., Asano N., Miura A., Iijima K., et al. The polymorphism interleukin 8-251 A/T influences the susceptibility of Helicobacter pylori related gastric diseases in the Japanese population. Gut 2005, 54:330-335.
13. Rutitzky L.I., Lopes da Rosa J.R., Stadecker M.J. Severe CD4 T cell-mediated immunopathology in murine schistosomiasis is dependent on IL-12p40 and correlates with high levels of IL-17. J Immunol 2005, 175:3920-3926.
14. Aggarwal S., Ghilardi N., Xie M.H., de Sauvage F.J., Gurney A.L. Interleukin-23 promotes a distinct CD4 T cell activation state characterized by the production of interleukin-17. J Biol Chem 2003, 278:1910-1914.
15. Kolls J.K., Linden A. Interleukin-17 family members and inflammation. Immunity 2004, 21:467-476.
16. Luzza F., Parrello T., Monteleone G., Sebkova L., Romano M., Zarrilli R., et al. Up-regulation of IL-17 is associated with bioactive IL-8 expression in Helicobacter pylori-infected human gastric mucosa. J Immunol 2000, 165:5332-5337.
17. Mizuno T., Ando T., Nobata K., Tsuzuki T., Maeda O., Watanabe O., et al. Interleukin-17 levels in Helicobacter pylori-infected gastric mucosa and pathologic sequelae of colonization. World J Gastroenterol 2005, 11:6305-6311.
18. Shibata T., Tahara T., Hirata I., Arisawa T. Genetic polymorphism of interleukin-17A and -17F genes in gastric carcinogenesis. Hum Immunol 2009, 70:547-551.
19. Arisawa T., Tahara T., Shibata T., Nagasaka M., Nakamura M., Kamiya Y., et al. The influence of polymorphisms of interleukin-17A and interleukin-17F genes on the susceptibility to ulcerative colitis. J Clin Immunol. 2008, 28:44-49.
20. Nordang G.B.N., Viken M.K., Hollis-Moffatt J.E., Merriman T.R., Forre O.T., Helgetveit K., et al. Association analysis of the interleukin 17A gene in Caucasian rheumatoid arthritis patients from Norway and New Zealand. Rheumatology 2009, 48:367-370.
21. Wu X., Zeng Z., Chen B., Yu J., Xue L., Hao Y., et al. Association between polymorphisms in interleukin-17A and interleukin-17F genes and risks of gastric cancer. Int J Cancer 2010, 127:86-92.
22. Chen J., Deng Y., Zhao J., Luo Z., Peng W., Yang J., et al. The polymorphism of IL-17 G-152A was associated with childhood asthma and bacterial colonization of the hypopharynx in bronchiolitis. J Clin Immunol 2010, 30:539-545.
23. Sebkova L., Pellicano A., Monteleone G., Grazioli B., Guarnieri G., Imeneo M., et al. Extracellular signal-regulated protein kinase mediates interleukin 17 (IL-17)-induced IL-8 secretion in Helicobacter pylori-infected human gastric epithelial cells. Infect Immun 2004, 72:5019-5026.
24. O'Connor W., Kamanaka M., Booth C.J., Town T., Nakae S., Iwakura Y., et al. A protective function for interleukin 17A in T cell-mediated intestinal inflammation. Nat Immunol. 2009, 10:603-609.
25. Ouyang W., Kolls J.K., Zheng Y. The biological functions of T helper 17 cell effector cytokines in inflammation. Immunity 2008, 28:454-467.
26. Zhang B., Rong G., Wei H., Zhang M., Bi J., Ma L., et al. The prevalence of Th17 cells in patients with gastric cancer. Biochem Biophys Res Commun 2008, 374:533-537.
27. Iida T., Iwahashi M., Katsuda M., Ishida K., Nakamori M., Nakamura M., et al. Tumor-infiltrating CD4+ Th17 cells produce IL-17 in tumor microenvironment and promote tumor progression in human gastric cancer. Oncol Rep 2011, 25:1271-1277.
28. Chen J., Xia J., Liang X., Pan K., Wang W., Lv L., et al. Intratumoral expression of IL-17 and its prognostic role in gastric adenocarcinoma patients. Int J Biol Sci 2011, 7:53-60.
29. Mi X., He H., Deng Y., et al. Lack of an association of miR-938 SNP in IDDM10 with human type 1 diabetes. Diabetol Metab Syndr 2010, 3:27.